These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 4213282

  • 1. Outpatient intravenous medications in the management of cystic fibrosis.
    Rucker RW, Harrison GM.
    Pediatrics; 1974 Sep; 54(3):358-60. PubMed ID: 4213282
    [No Abstract] [Full Text] [Related]

  • 2. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR, Pressler T, Høiby N.
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [Abstract] [Full Text] [Related]

  • 3. [Intravenous administration of antibiotics in the treatment of cystic fibrosis].
    Vávrová V, Lochmann O, Suková B, Copová M, Zapletal A, Absolonová V, Houstĕk J.
    Cesk Pediatr; 1986 Oct; 41(10):605-7. PubMed ID: 3502950
    [No Abstract] [Full Text] [Related]

  • 4. [Pathogenesis and diagnosis of bacterial airway infections in patients with cystic fibrosis].
    Möller AV, van Alphen L, Dankert-Roelse JE, Dankert J.
    Ned Tijdschr Geneeskd; 1995 Nov 18; 139(46):2346-9. PubMed ID: 7501072
    [No Abstract] [Full Text] [Related]

  • 5. [Cystic fibrosis: current therapy. Antibiotics].
    Tamm M, Héritier F, Rappaz I, Schaad UB.
    Schweiz Med Wochenschr Suppl; 2000 Nov 18; 122():33S-37S. PubMed ID: 12536469
    [No Abstract] [Full Text] [Related]

  • 6. Eradication of Pseudomonas aeruginosa in cystic fibrosis.
    Eber E, Thalhammer GH, Zach MS.
    Eur Respir J; 2006 Feb 18; 27(2):438-9. PubMed ID: 16452606
    [No Abstract] [Full Text] [Related]

  • 7. Cystic fibrosis: intravenous treatment at home.
    Catchpole A.
    Nurs Times; 2006 Feb 18; 85(12):40-2. PubMed ID: 2717454
    [No Abstract] [Full Text] [Related]

  • 8. [Strategy of antibiotic therapy by various routes of administration in the initial colonization by Pseudomonas aeruginosa].
    Châtain P.
    Rev Mal Respir; 2003 Apr 18; 20(2 Pt 2):S105-12. PubMed ID: 12910142
    [No Abstract] [Full Text] [Related]

  • 9. Home intravenous therapy using a silastic long line catheter in cystic fibrosis patients.
    Pradeepkumar VK, Waseem E, Shortt C, Barry D, Watson JB.
    Ir Med J; 1992 Sep 18; 85(3):110-1. PubMed ID: 1399475
    [Abstract] [Full Text] [Related]

  • 10. Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa.
    Béghin L, Michaud L, Loeuille GA, Wizla-Derambure N, Sayah H, Sardet A, Thumerelle C, Deschildre A, Turck D, Gottrand F.
    Pediatr Pulmonol; 2009 May 18; 44(5):464-71. PubMed ID: 19360849
    [Abstract] [Full Text] [Related]

  • 11. Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis.
    Conway SP, Etherington C, Munday J, Goldman MH, Strong JJ, Wootton M.
    Ann Pharmacother; 2000 Nov 18; 34(11):1238-42. PubMed ID: 11098334
    [Abstract] [Full Text] [Related]

  • 12. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Malmborg AS, Alfredsson H, Kusoffsky E, Strandvik B.
    Scand J Infect Dis Suppl; 1981 Nov 18; 29():64-9. PubMed ID: 6947407
    [Abstract] [Full Text] [Related]

  • 13. Implementation of European standards of care for cystic fibrosis--control and treatment of infection.
    Elborn JS, Hodson M, Bertram C.
    J Cyst Fibros; 2009 May 18; 8(3):211-7. PubMed ID: 19372063
    [Abstract] [Full Text] [Related]

  • 14. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK, Olesen HV, Høiby N, Johannesson M, Karpati F, Laerum BN, Meyer P, Pressler T, Lindblad A, Scandinavian CF Study Consortium (SCFSC).
    J Cyst Fibros; 2009 Mar 18; 8(2):135-42. PubMed ID: 19157995
    [Abstract] [Full Text] [Related]

  • 15. Editorial overview: clinical utility of synergy testing for multidrug resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
    Middleton PG.
    Paediatr Respir Rev; 2007 Sep 18; 8(3):262-3, quiz 263-4. PubMed ID: 17868925
    [No Abstract] [Full Text] [Related]

  • 16. Duration of intravenous antibiotic treatment for respiratory exacerbations in children with cystic fibrosis.
    Brown SM, Balfour-Lynn IM.
    Arch Dis Child; 2010 Jul 18; 95(7):568. PubMed ID: 20522458
    [No Abstract] [Full Text] [Related]

  • 17. [Anti-Pseudomonas aerosol therapy in cystic fibrosis: improvement with tobramycin].
    Foucaud P, Borel B, Charara O, Nathanson S, Petitprez P, Pin I.
    Rev Pneumol Clin; 2002 Jun 18; 58(3 Pt 1):131-8. PubMed ID: 12486796
    [Abstract] [Full Text] [Related]

  • 18. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].
    Hubert D, Desmazes-Dufeu N, Dusser D.
    Rev Mal Respir; 2003 Apr 18; 20(2 Pt 2):S129-35. PubMed ID: 12910145
    [No Abstract] [Full Text] [Related]

  • 19. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN, Ratjen F.
    Semin Respir Crit Care Med; 2009 Oct 18; 30(5):587-95. PubMed ID: 19760546
    [Abstract] [Full Text] [Related]

  • 20. [Ochrobactrum anthropi bacteremia in a child with cystic fibrosis].
    Yagüe-Muñoz A, Gregori-Roig P, Valls-López S, Pantoja-Martínez J.
    Enferm Infecc Microbiol Clin; 2010 Feb 18; 28(2):137-8. PubMed ID: 19811858
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.